logo

Clinical Trial Calendar

Share
Company Name Eiger BioPharmaceuticals Inc.
Event Name Topline data from phase II study with Ubenimex (LIBERTY)
Indication Pulmonary arterial hypertension
Outcome Date 01/16/2018
Outcome Study failed; results reported on Jan.16, 2018
Result Date Q1 2018
News
http://www.eigerbio.com/news/
Return to Clinical Trial Calendar